282 related articles for article (PubMed ID: 33546181)
1. Injectable Capsaicin for the Management of Pain Due to Osteoarthritis.
Campbell JN; Stevens R; Hanson P; Connolly J; Meske DS; Chung MK; Lascelles BDX
Molecules; 2021 Feb; 26(4):. PubMed ID: 33546181
[TBL] [Abstract][Full Text] [Related]
2. Capsaicin-based therapies for pain control.
Smith H; Brooks JR
Prog Drug Res; 2014; 68():129-46. PubMed ID: 24941667
[TBL] [Abstract][Full Text] [Related]
3. Ca
Wang S; Wang S; Asgar J; Joseph J; Ro JY; Wei F; Campbell JN; Chung MK
J Biol Chem; 2017 May; 292(20):8291-8303. PubMed ID: 28360106
[TBL] [Abstract][Full Text] [Related]
4. Capsaicin for neuropathic pain: linking traditional medicine and molecular biology.
Haanpää M; Treede RD
Eur Neurol; 2012; 68(5):264-75. PubMed ID: 23037991
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic potential of vanilloid receptor TRPV1 agonists and antagonists as analgesics: Recent advances and setbacks.
Wong GY; Gavva NR
Brain Res Rev; 2009 Apr; 60(1):267-77. PubMed ID: 19150372
[TBL] [Abstract][Full Text] [Related]
6. Presynaptic inhibition of transient receptor potential vanilloid type 1 (TRPV1) receptors by noradrenaline in nociceptive neurons.
Chakraborty S; Elvezio V; Kaczocha M; Rebecchi M; Puopolo M
J Physiol; 2017 Apr; 595(8):2639-2660. PubMed ID: 28094445
[TBL] [Abstract][Full Text] [Related]
7. Fight fire with fire: Neurobiology of capsaicin-induced analgesia for chronic pain.
Arora V; Campbell JN; Chung MK
Pharmacol Ther; 2021 Apr; 220():107743. PubMed ID: 33181192
[TBL] [Abstract][Full Text] [Related]
8. Phα1β toxin prevents capsaicin-induced nociceptive behavior and mechanical hypersensitivity without acting on TRPV1 channels.
Castro-Junior CJ; Milano J; Souza AH; Silva JF; Rigo FK; Dalmolin G; Cordeiro MN; Richardson M; Barros AG; Gomez RS; Silva MA; Kushmerick C; Ferreira J; Gomez MV
Neuropharmacology; 2013 Aug; 71():237-46. PubMed ID: 23597507
[TBL] [Abstract][Full Text] [Related]
9. Ablation of TRPV1+ Afferent Terminals by Capsaicin Mediates Long-Lasting Analgesia for Trigeminal Neuropathic Pain.
Wang S; Bian C; Yang J; Arora V; Gao Y; Wei F; Chung MK
eNeuro; 2020; 7(3):. PubMed ID: 32404326
[TBL] [Abstract][Full Text] [Related]
10. Increased function of pronociceptive TRPV1 at the level of the joint in a rat model of osteoarthritis pain.
Kelly S; Chapman RJ; Woodhams S; Sagar DR; Turner J; Burston JJ; Bullock C; Paton K; Huang J; Wong A; McWilliams DF; Okine BN; Barrett DA; Hathway GJ; Walsh DA; Chapman V
Ann Rheum Dis; 2015 Jan; 74(1):252-9. PubMed ID: 24152419
[TBL] [Abstract][Full Text] [Related]
11. Design and characterization of a noncompetitive antagonist of the transient receptor potential vanilloid subunit 1 channel with in vivo analgesic and anti-inflammatory activity.
García-Martínez C; Fernández-Carvajal A; Valenzuela B; Gomis A; Van Den Nest W; Ferroni S; Carreño C; Belmonte C; Ferrer-Montiel A
J Pain; 2006 Oct; 7(10):735-46. PubMed ID: 17018334
[TBL] [Abstract][Full Text] [Related]
12. [TRPV1 in neuropathic pain: from animal models to therapeutical prospects].
Danigo A; Magy L; Demiot C
Med Sci (Paris); 2013; 29(6-7):597-606. PubMed ID: 23859514
[TBL] [Abstract][Full Text] [Related]
13. Capsaicin 8% dermal patch in clinical practice: an expert opinion.
Bonezzi C; Costantini A; Cruccu G; Fornasari DMM; Guardamagna V; Palmieri V; Polati E; Zini P; Dickenson AH
Expert Opin Pharmacother; 2020 Aug; 21(11):1377-1387. PubMed ID: 32511032
[TBL] [Abstract][Full Text] [Related]
14. Antinociceptive activity of transient receptor potential channel TRPV1, TRPA1, and TRPM8 antagonists in neurogenic and neuropathic pain models in mice.
Sałat K; Filipek B
J Zhejiang Univ Sci B; 2015 Mar; 16(3):167-78. PubMed ID: 25743118
[TBL] [Abstract][Full Text] [Related]
15. Psychophysical and vasomotor evidence for interdependency of TRPA1 and TRPV1-evoked nociceptive responses in human skin: an experimental study.
Nielsen TA; Eriksen MA; Gazerani P; Andersen HH
Pain; 2018 Oct; 159(10):1989-2001. PubMed ID: 29847470
[TBL] [Abstract][Full Text] [Related]
16. Capsaicin and sensory neurones: a historical perspective.
Szolcsányi J
Prog Drug Res; 2014; 68():1-37. PubMed ID: 24941663
[TBL] [Abstract][Full Text] [Related]
17. TRPV1 receptors in the CNS play a key role in broad-spectrum analgesia of TRPV1 antagonists.
Cui M; Honore P; Zhong C; Gauvin D; Mikusa J; Hernandez G; Chandran P; Gomtsyan A; Brown B; Bayburt EK; Marsh K; Bianchi B; McDonald H; Niforatos W; Neelands TR; Moreland RB; Decker MW; Lee CH; Sullivan JP; Faltynek CR
J Neurosci; 2006 Sep; 26(37):9385-93. PubMed ID: 16971522
[TBL] [Abstract][Full Text] [Related]
18. Privileged crosstalk between TRPV1 channels and mitochondrial calcium shuttling machinery controls nociception.
Nita II; Caspi Y; Gudes S; Fishman D; Lev S; Hersfinkel M; Sekler I; Binshtok AM
Biochim Biophys Acta; 2016 Dec; 1863(12):2868-2880. PubMed ID: 27627464
[TBL] [Abstract][Full Text] [Related]
19. Capsaicin (TRPV1 Agonist) therapy for pain relief: farewell or revival?
Knotkova H; Pappagallo M; Szallasi A
Clin J Pain; 2008 Feb; 24(2):142-54. PubMed ID: 18209521
[TBL] [Abstract][Full Text] [Related]
20. Amelioration of neuropathic pain by novel transient receptor potential vanilloid 1 antagonist AS1928370 in rats without hyperthermic effect.
Watabiki T; Kiso T; Kuramochi T; Yonezawa K; Tsuji N; Kohara A; Kakimoto S; Aoki T; Matsuoka N
J Pharmacol Exp Ther; 2011 Mar; 336(3):743-50. PubMed ID: 21098091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
